Edition:
United States

Halozyme Therapeutics Inc (HALO.O)

HALO.O on Nasdaq

9.24USD
22 Jul 2016
Change (% chg)

$-0.11 (-1.18%)
Prev Close
$9.35
Open
$9.35
Day's High
$9.40
Day's Low
$9.15
Volume
1,108,950
Avg. Vol
1,561,923
52-wk High
$25.25
52-wk Low
$6.96

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.28 December 23 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 6 32.38 40.00 28.30 40.90
Quarter Ending Dec-16 6 35.97 50.50 28.50 43.70
Year Ending Dec-16 7 138.74 152.00 127.60 127.01
Year Ending Dec-17 7 177.54 244.60 132.20 173.38
Earnings (per share)
Quarter Ending Sep-16 8 -0.28 -0.16 -0.35 -0.05
Quarter Ending Dec-16 8 -0.29 -0.18 -0.43 -0.03
Year Ending Dec-16 8 -1.03 -0.74 -1.26 -0.22
Year Ending Dec-17 7 -0.77 0.04 -1.42 0.17

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 29.65 42.50 12.85 43.33
Quarter Ending Dec-15 42.06 52.23 10.16 24.16
Quarter Ending Sep-15 24.01 20.78 3.23 13.46
Quarter Ending Jun-15 25.12 43.38 18.27 72.73
Quarter Ending Mar-15 19.40 18.67 0.74 3.79
Earnings (per share)
Quarter Ending Mar-16 -0.20 -0.16 0.04 -20.00
Quarter Ending Dec-15 -0.08 0.03 0.11 -140.00
Quarter Ending Sep-15 -0.16 -0.19 0.03 -16.35
Quarter Ending Jun-15 -0.09 0.02 0.11 -122.57
Quarter Ending Mar-15 -0.13 -0.12 0.01 -9.43

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 32.38 32.38 32.38 32.46 40.90
Quarter Ending Dec-16 35.97 35.97 35.97 35.95 43.70
Year Ending Dec-16 138.74 138.74 138.74 138.74 127.01
Year Ending Dec-17 177.54 177.54 177.54 177.54 173.38
Earnings (per share)
Quarter Ending Sep-16 -0.28 -0.28 -0.28 -0.28 -0.05
Quarter Ending Dec-16 -0.29 -0.29 -0.29 -0.29 -0.03
Year Ending Dec-16 -1.03 -1.03 -1.03 -1.02 -0.22
Year Ending Dec-17 -0.77 -0.77 -0.77 -0.75 0.17

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : S&P Capital IQ Quantitative Report
$104.00
Provider : Stock Traders Daily
$20.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.